Zusammenfassung
Für die Behandlung von Lebermetastasen bietet die interventionelle Radiologie sowohl lokale wie lokoregionäre Therapiekonzepte an. Während lokale Konzepte als bildgeführte interstitielle Techniken eingesetzt werden, ist für die lokoregionäre Verteilung von antitumorösen Wirkstoffen der vaskuläre Zugang ideal. In diesem Artikel werden von den derzeit interstitiell eingesetzten Ablationsmethoden die Radiofrequenz, die laserinduzierte Thermotherapie und die CT-gesteuerte Brachytherapie anhand der verfügbaren Literatur bewertet. Aus dem Bereich der lokoregionär vaskulären Techniken finden sich Analysen der intraarteriellen Chemotherapie über minimalinvasiv implantierte Portsysteme sowie die transarterielle Chemoembolisation.
Abstract
Interventional radiology offers not only local but also loco-regional therapeutic concepts for the treatment of liver metastases. While the local concepts are employed as image-guided, interstitial techniques, a vascular access is ideal for the loco-regional distribution of anti-tumour drugs. In the present article interstitial employed ablation methods such as radiofrequency ablation, laser-induced thermotherapy and CT-guided brachytherapy are evaluated on the basis of the available literature. The field of loco-regional vascular techniques contributes analyses of intra-arterial chemotherapy via minimally invasively implanted port systems as well as transarterial chemoembolisation.
Schlüsselwörter
Tumorablation - Lebermetastasen - Chemotherapie - Intervention
Key words
Tumour ablation - liver metastases - chemotherapy - interventions
Literatur
-
1
Tacke J, Adam G, Speetzen R. et al .
MR-guided interstitial cryotherapy of the liver with a novel, nitrogen-cooled cryoprobe.
Magn Reson Med.
1998;
39 (3)
354-360
-
2
Kennedy J E, Ter Haar G R, Cranston D.
High intensity focused ultrasound. surgery of the future?.
Br J Radiol.
2003;
76 (909)
590-599
-
3
Shiina S, Tagawa K, Unuma T. et al .
Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study.
Cancer.
1991;
68 (7)
1524-1530
-
4
Seki T, Wakabayashi M, Nakagawa T. et al .
Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma. comparison with percutaneous ethanol injection therapy.
Cancer.
1999;
85 (8)
1694-1702
-
5
Rossi S, Fornari F, Pathies C. et al .
Thermal lesions induced by 480 KHz localized current field in guinea pig and pig liver.
Tumori.
1990;
76
54-57
-
6
Pereira P L, Trubenbach J, Schmidt D.
Radiofrequency ablation. basic principles, techniques and challenges.
Fortschr Rontgenstr.
2003;
175 (1)
20-27
-
7
Jung E M, Clevert D A, Rupp N.
Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors.
Fortschr Rontgenstr.
2003;
175 (10)
1403-1412
-
8
Stroszczynski C, Gretschel S, Gaffke G. et al .
Laser-induced thermotherapy (LITT) for malignant liver tumours. the role of sonography in catheter placement and observation of the therapeutic procedure.
Ultraschall Med.
2002;
23 (3)
163-167
-
9
Pech M, Werk M, Beck A. et al .
Systemkonstanz und Energieverteilung bei Laser-induzierter interstitieller Thermotherapie (LITT).
Fortschr Rontgenstr.
2002;
174 (6)
754-760
-
10
Solbiati G, Goldberg S N, Ierace T. et al .
Hepatic metastases. percutaneous radiofrequency ablation with cooled-tip electrodes. .
Radiology.
1997;
205
367-373
-
11
Solbiati L, Livraghi T, Goldberg S N. et al .
Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer. long-term results in 117 patients.
Radiology.
2001;
221 (1)
159-166
-
12
de Baere T, Elias D, Dromain C.
Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year.
Am J Roentgenol.
2000;
175
1619-1625
-
13
Gewiese B, Beuthan J, Fobbe F. et al .
Magnetic resonance imaging-controlled laser-induced interstitial thermotherapy.
Invest Radiol.
1994;
29 (3)
345-351
-
14
Pech M, Werk M, Beck A. et al .
Lokalrezidive und Progress nach LITT. Welche MR-Sequenz ist besser?.
Fortschr Rontgenstr.
2004;
176
550-555
-
15
Vogl T J, Muller P, Hirsch H. et al .
Laser-induced thermotherapy of liver metastases with MRI control. Prospective results of an optimized therapy procedure.
Radiologe.
1995;
35 (3)
188-199
-
16
Mack M G, Straub R, Eichler K. et al .
Percutaneous MR imaging-guided laser-induced thermotherapy of hepatic metastases.
Abdom Imaging.
2000;
26 (4)
369-374
-
17
Vogl T J, Straub R, Eichler K. et al .
Malignant Liver Tumors Treated with MR Imaging-guided Laser-induced Thermotherapy. Experience with Complications in 899 Patients (2,520 lesions).
Radiology.
2002;
225 (2)
367-377
-
18
Tacke J.
Perkutane Radiofrequenzablation - klinische Indikationen und Ergebnisse.
Fortschr Rontgenstr.
2003;
175 (2)
156-168
-
19
Rhim H.
Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow: comparison with standard percutaneous radiofrequency ablation therapy.
Cancer.
2003;
98 (2)
433-434
-
20
Mulier S, Ni Y, Miao Y. et al .
Size and geometry of hepatic radiofrequency lesions.
Eur J Surg Oncol.
2003;
29 (10)
867-878
-
21
Germer C T, Isbert C, Albrecht D. et al .
Laser-induced thermotherapy combined with hepatic arterial embolization in the treatment of liver tumors in a rat tumor model.
Ann Surg.
1999;
230 (1)
55-62
-
22
Ricke J, Wust P, Stohlmann A. et al .
CT-Guided Interstitial Brachytherapy of Liver Malignancies alone or in combination with Thermal Ablation. Phase I/II Results of a Novel Technique.
Int J Radiat Onc Biol Phys.
2004;
58
1496-1505
-
23
Dritschilo A, Harter K W, Thomas D. et al .
Intraoperative radiation therapy of hepatic metastases. technical aspects and report of a pilot study.
Int J Radiat Oncol Biol Phys.
1988;
14 (5)
1007-1011
-
24
Thomas D S, Nauta R J, Rodgers J E. et al .
Intraoperative high-dose rate interstitial irradiation of hepatic metastases from colorectal carcinoma. Results of a phase I-II trial.
Cancer.
1993;
71 (6)
1977-1981
-
25
McGinn C J, Ten Haken R K, Ensminger W D. et al .
Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model.
J Clin Oncol.
1998;
16 (6)
2246-2252
-
26
Herfarth K K, Debus J, Lohr F. et al .
Wannenmacher M Stereotactic single dose radiation therapy of liver tumors. Results of a phase I/II trial.
J Clin Oncol.
2001;
19
164-170
-
27
Ricke J, Wust P, Stohlmann A. et al .
CT-gesteuerte Brachytherapie. Eine neue perkutane Technik zur interstitiellen Ablation von Lebermetastasen.
Strahlenther Onkol.
2004;
180
274-280
-
28
Sullivan R D, Norcross J W, Watkins E.
Chemotherapy for metastastic liver cancer by prolonged hepatic-artery infusion.
N Engl J Med.
1964;
270
321-327
-
29
Breedis C, Young G.
The blood supply of neoplasms in the liver.
Am J Pathol.
1954;
30 (5)
969-977
-
30
Pohlen U, Berger G, Binnenhei M. et al .
Increased carboplatin concentration in liver tumors through temporary flow retardation with starch microspheres (Spherex) and gelatin powder (Gelfoam). an experimental study in liver tumor-bearing rabbits.
J Surg Res.
2000;
92 (2)
165-170
-
31
Collins J M.
Pharmacologic rationale for regional drug delivery.
J Clin Oncol.
1984;
2 (5)
498-504
-
32
Ishikawa H, Kikkawa F, Tamakoshi K. et al .
Distribution of platinum in human gynecologic tissues and lymph nodes after intravenous and intraarterial neoadjuvant chemotherapy.
Anticancer Res.
1996;
16 (6B)
3849-3853
-
33
Sileni V C, Fosser V, Maggian P. et al .
Pharmacokinetics and tumor concentration of intraarterial and intravenous cisplatin in patients with head and neck squamous cancer.
Cancer Chemother Pharmacol.
1992;
30 (3)
221-225
-
34
Schuller J, Czejka M J, Jager W. et al .
Comparative bioavailability of fluorouracil and its prodrug, ftorafur, following intra-arterial, intravenous and preoral administration.
Pharmazie.
1991;
46 (8)
587-588
-
35
Chang A E, Schneider P D, Sugarbaker P H. et al .
A prospective randomized trial of regional versus systematic continuous fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases.
Ann Surg.
1987;
206
685-693
-
36
Martin J K Jr, O’Connell M J, Wieand H S. et al .
Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer.
Arch Surg.
1990;
125
1022-1027
-
37
Kemeny M M, Goldberg D, Beatty J D. et al .
Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal cancer.
Cancer.
1986;
57
492-498
-
38
Rougier P, Laplanche A, Huguier M. et al .
Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma. Long-term results of a prospective randomized trial.
J Clin Oncol.
1992;
10
1112-1118
-
39
Allen-Mersh T G, Earlam S, Fordy C. et al .
Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.
Lancet.
1994;
344
1255-1260
-
40
Kerr D J, McArdle C S, Ledermann J. et al .
Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases. a multicentre randomised trial.
Lancet.
2003;
361
368-373
-
41
Lorenz M, Muller H H.
Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.
J Clin Oncol.
2000;
18
243-254
-
42
O’Connell M J, Nagorney D M, Bernath A M. et al .
Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver.
J Clin Oncol.
1998;
16
2528-2533
-
43
Kemeny N, Huang Y, Cohen A M. et al .
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.
N Engl J J Med.
1999;
341 (27)
2039-2048
-
44
Kemeny N, Daly J, Reichman B. et al .
Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.
Ann Intern Med.
1987;
107 (4)
459-465
-
45
Hohn D C, Stagg R J, Friedman M A. et al .
A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to liver. the Northern Oncology Group trial.
J Clin Oncol.
1989;
7
1646-1654
-
46
Herrmann K A, Waggershauser T, Sittek H. et al .
Liver intraarterial chemotherapy. use of the femoral artery for percutaneous implantation of catheter-port systems.
Radiology.
2000;
215
294-299
-
47
Tanaka T, Arai Y, Inaba Y. et al .
Radiologic Placement of Side-hole Catheter with Tip Fixation for Hepatic Arterial Infusion Chemotherapy.
J Vasc Interv Radiol.
2003;
14
63-68
-
48
Ricke J, Hildebrandt B, Miersch A. et al .
Interventional Placement of Hepatic Arterial Port Systems. An Outcome Assessment including different Strategies in Anatomic Variants of the Celiac Branch.
J Vasc Interv Radiol.
2004;
15
825-833
-
49
Tanaka T, Arai Y, Inaba Y. et al .
Radiologic Placement of Side-hole Catheter with Tip Fixation for Hepatic Arterial Infusion Chemotherapy.
J Vasc Interv Radiol.
2003;
14
63-68
-
50
Wickremesekera J K, Cannan R J, Stubbs R S.
Hepatic artery access ports. recognizing and avoiding the problems.
Aust NZ J Surg.
2000;
70
496-502
-
51
Dizon D S, Kemeny N E.
Intrahepatic arterial infusion of chemotherapy. clinical results.
Semin Oncol.
2002;
29 (2)
126-135
-
52
Tsalic M, Bar-Sela G, Beny A. et al .
Severe toxicity related to the 5-fluorouracil/leucovorin combination (the Mayo Clinic regimen): a prospective study in colorectal cancer patients.
Am J Clin Oncol.
2003;
26
103-106
-
53
Vincent M, Ho C, Tomiak A. et al .
Toxicity analysis of the 5-day bolus 5-fluorouracil/folinic acid regimen for the treatment of colorectal carcinoma from 2 randomized controlled trials. a concern about dose.
Clin Colorectal Cancer.
2002;
2
111-118
-
54
Allen-Mersh T G, Earlam S, Fordy C. et al .
Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.
Lancet.
1994;
344 (8932)
1255-1260
-
55
Raoul J L, Heresbach D, Bretagne J F. et al .
Chemoembolization of hepatocellular carcinomas. A study of the biodistribution and pharmacokinetics of doxorubicin.
Cancer.
1992;
70 (3)
585-590
-
56
Kruskal J B, Hlatky L, Hahnfeldt P. et al .
In vivo and in vitro analysis of the effectiveness of doxorubicin combined with temporary arterial occlusion in liver tumors.
J Vasc Interv Radiol.
1993;
4 (6)
741-747
-
57
Kameyama M, Imaoka S, Fukuda I. et al .
Delayed washout of intratumor blood flow is associated with good response to intraarterial chemoembolization for liver metastasis of colorectal cancer.
Surgery.
1993;
114 (1)
97-101
-
58
Mavligit G M, Pollock R E, Evans H L. et al .
Durable hepatic tumor regression after arterial chemoembolization-infusion in patients with islet cell carcinoma of the pancreas metastatic to the liver.
Cancer.
1993;
72 (2)
375-380
-
59
Therasse E, Breittmayer F, Roche A. et al .
Transcatheter chemoembolization of progressive carcinoid liver metastasis.
adiology.
1993;
189 (2)
541-547
-
60
Stokes K R, Stuart K, Clouse M E.
Hepatic arterial chemoembolization for metastatic endocrine tumors.
J Vasc Interv Radiol.
1993;
4 (3)
341-345
-
61
Scheele J, Altendorf-Hofmann A, Grube T. et al .
Resection of colorectal liver metastases. What prognostic factors determine patient selection?.
Chirurg.
2001;
72 (5)
547-560
-
62
Lambert L A, Colacchio T A, Barth R J.
Interval hepatic resection of colorectal metastases improves patient selection.
Curr Surg.
2000;
57 (5)
504
-
63
Livraghi T, Solbiati L, Meloni F. et al .
Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the „test-of-time approach”.
Cancer.
2003;
97 (12)
3027-3035
-
64
Isbert C, Boerner A, Ritz J P. et al .
In situ ablation of experimental liver metastases delays and reduces residual intrahepatic tumour growth and peritoneal tumour spread compared with hepatic resection.
Br J Surg.
2002;
89 (10)
1252-1259
-
65
Helmberger T, Holzknecht N, Schöpf U. et al .
Radiofrequenzablation von Lebermetastasen Technik und erste Ergebnisse.
Radiologe.
2001;
41
69-76
-
66
Gillams A R, Lees W R.
Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer.
Dis Colon Rectum.
2000;
43 (5)
656-661
-
67
Livraghi T, Goldberg S N, Solbiati L. et al .
Percutaneous radio-frequency ablation of liver metastases from breast cancer. initial experience in 24 patients.
Radiology.
2001;
220
145-149
Prof. Dr. J. Ricke
Klinik für Strahlenheilkunde, Charité Virchow-Klinikum
Augustenburger Platz 1
13353 Berlin
Phone: ++ 49/30/4 50 55 70 01
Fax: ++ 49/30/4 50 55 79 01
Email: jens.ricke@charite.de
